Pediatrix Medical Group (MD) Expected to Announce Earnings on Thursday

Pediatrix Medical Group (NYSE:MD) is expected to issue its Q4 2025 results before the market opens on Thursday, February 19th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $486.23 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 19, 2026 at 9:00 AM ET.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $21.50 on Thursday. Pediatrix Medical Group has a 12 month low of $11.84 and a 12 month high of $24.99. The stock has a market capitalization of $1.85 billion, a PE ratio of 11.32 and a beta of 0.76. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.65. The firm has a 50 day moving average of $21.72 and a 200-day moving average of $19.19.

Insider Transactions at Pediatrix Medical Group

In other Pediatrix Medical Group news, CEO Mark S. Ordan sold 23,000 shares of the business’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $22.41, for a total transaction of $515,430.00. Following the sale, the chief executive officer owned 302,805 shares of the company’s stock, valued at $6,785,860.05. The trade was a 7.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael A. Rucker sold 10,478 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $23.00, for a total value of $240,994.00. Following the sale, the director owned 59,101 shares in the company, valued at approximately $1,359,323. The trade was a 15.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.90% of the stock is currently owned by insiders.

Institutional Trading of Pediatrix Medical Group

Large investors have recently bought and sold shares of the company. Global Retirement Partners LLC raised its stake in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after buying an additional 1,365 shares during the last quarter. Los Angeles Capital Management LLC bought a new position in Pediatrix Medical Group in the 4th quarter worth approximately $43,000. Canada Pension Plan Investment Board purchased a new stake in shares of Pediatrix Medical Group during the 2nd quarter worth approximately $83,000. Quantbot Technologies LP purchased a new position in shares of Pediatrix Medical Group in the 2nd quarter worth $99,000. Finally, Tower Research Capital LLC TRC increased its stake in Pediatrix Medical Group by 219.3% during the second quarter. Tower Research Capital LLC TRC now owns 7,685 shares of the company’s stock worth $110,000 after acquiring an additional 5,278 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MD shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. Truist Financial upped their price objective on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a “hold” rating in a research note on Monday, November 10th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Finally, Zacks Research lowered shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $21.00.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.